{"id":63488,"date":"2016-03-04T15:39:58","date_gmt":"2016-03-04T15:39:58","guid":{"rendered":"https:\/\/leitat.org\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/"},"modified":"2025-02-24T21:55:57","modified_gmt":"2025-02-24T21:55:57","slug":"batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases","status":"publish","type":"post","link":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/","title":{"rendered":"BATCure Kick off meeting &#8211; New therapeutic options for a group of rare lysosomal diseases"},"content":{"rendered":"<p style=\"text-align: justify;\">The first meeting of the BATCure group took place at UCL in London on January 27-29. It was a very exciting to finally be starting on the project with over 30 scientists, research students and clinicians attending from Denmark, Germany, Italy, Latvia, Spain, Sweden and the UK.<\/p>\n<p style=\"text-align: justify;\">The BDFA are an integral part of the project to provide the patient voice and Heather Band, BDFA Scientific Officer talked about our part in the work and to introduced the BDFA. Several groups taking part are new to the field of Batten research and were keen to hear about family experiences and how important research is to our community.<\/p>\n<p style=\"text-align: justify;\">More information <a href=\"http:\/\/www.bdfa-uk.org.uk\/batcure-kick-off-meeting\/\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a>.<\/p>\n<p style=\"text-align: justify;\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone wp-image-5673 \" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure1-680x380-1.jpg\" alt=\"\" width=\"471\" height=\"263\" data-id=\"5673\" srcset=\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure1-680x380-1.jpg 680w, https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure1-680x380-1-300x168.jpg 300w\" sizes=\"(max-width: 471px) 100vw, 471px\" \/> <img decoding=\"async\" class=\"alignnone wp-image-5674 \" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1.jpg\" alt=\"\" width=\"266\" height=\"266\" data-id=\"5674\" srcset=\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1.jpg 500w, https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1-150x150.jpg 150w, https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1-300x300.jpg 300w\" sizes=\"(max-width: 266px) 100vw, 266px\" \/> <img decoding=\"async\" class=\"alignnone wp-image-5675 \" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure3-e1454692832558-500x500-1.jpg\" alt=\"\" width=\"266\" height=\"266\" data-id=\"5675\" srcset=\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure3-e1454692832558-500x500-1.jpg 500w, https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure3-e1454692832558-500x500-1-150x150.jpg 150w, https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure3-e1454692832558-500x500-1-300x300.jpg 300w\" sizes=\"(max-width: 266px) 100vw, 266px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The first meeting of the BATCure group took place at UCL in London on January 27-29. It was a very exciting to finally be starting on the project with over 30 scientists, research students and clinicians attending from Denmark, Germany, Italy, Latvia, Spain, Sweden and the UK. The BDFA are an integral part of the [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":46069,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[142],"tags":[208],"class_list":["post-63488","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-technologies-en","tag-blog-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New therapeutic options for a group of rare lysosomal diseases<\/title>\n<meta name=\"description\" content=\"BATCure Kick off meeting - New therapeutic options for a group of rare lysosomal diseases. A European project funded under H2020 programme.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New therapeutic options for a group of rare lysosomal diseases\" \/>\n<meta property=\"og:description\" content=\"BATCure Kick off meeting - New therapeutic options for a group of rare lysosomal diseases. A European project funded under H2020 programme.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"Leitat Technological Center\" \/>\n<meta property=\"article:published_time\" content=\"2016-03-04T15:39:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-24T21:55:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Comunicaci\u00f3n Leitat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Comunicaci\u00f3n Leitat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/\"},\"author\":{\"name\":\"Comunicaci\u00f3n Leitat\",\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/person\/ca8dc97489cd821df9e0c42930e89131\"},\"headline\":\"BATCure Kick off meeting &#8211; New therapeutic options for a group of rare lysosomal diseases\",\"datePublished\":\"2016-03-04T15:39:58+00:00\",\"dateModified\":\"2025-02-24T21:55:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/\"},\"wordCount\":124,\"publisher\":{\"@id\":\"https:\/\/leitat.org\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1.jpg\",\"keywords\":[\"Blog News\"],\"articleSection\":[\"Health technologies\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/\",\"url\":\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/\",\"name\":\"New therapeutic options for a group of rare lysosomal diseases\",\"isPartOf\":{\"@id\":\"https:\/\/leitat.org\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1.jpg\",\"datePublished\":\"2016-03-04T15:39:58+00:00\",\"dateModified\":\"2025-02-24T21:55:57+00:00\",\"description\":\"BATCure Kick off meeting - New therapeutic options for a group of rare lysosomal diseases. A European project funded under H2020 programme.\",\"breadcrumb\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#primaryimage\",\"url\":\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1.jpg\",\"contentUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1.jpg\",\"width\":500,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"HOME\",\"item\":\"https:\/\/leitat.org\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BATCure Kick off meeting &#8211; New therapeutic options for a group of rare lysosomal diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/leitat.org\/en\/#website\",\"url\":\"https:\/\/leitat.org\/en\/\",\"name\":\"Leitat Technological Center\",\"description\":\"Managing Technologies\",\"publisher\":{\"@id\":\"https:\/\/leitat.org\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/leitat.org\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/leitat.org\/en\/#organization\",\"name\":\"Leitat Technological Center\",\"url\":\"https:\/\/leitat.org\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg\",\"contentUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg\",\"width\":226,\"height\":78,\"caption\":\"Leitat Technological Center\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/person\/ca8dc97489cd821df9e0c42930e89131\",\"name\":\"Comunicaci\u00f3n Leitat\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g\",\"caption\":\"Comunicaci\u00f3n Leitat\"},\"sameAs\":[\"https:\/\/leitat.org\"],\"url\":\"https:\/\/leitat.org\/en\/blog\/author\/comunica-wp\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New therapeutic options for a group of rare lysosomal diseases","description":"BATCure Kick off meeting - New therapeutic options for a group of rare lysosomal diseases. A European project funded under H2020 programme.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"New therapeutic options for a group of rare lysosomal diseases","og_description":"BATCure Kick off meeting - New therapeutic options for a group of rare lysosomal diseases. A European project funded under H2020 programme.","og_url":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/","og_site_name":"Leitat Technological Center","article_published_time":"2016-03-04T15:39:58+00:00","article_modified_time":"2025-02-24T21:55:57+00:00","og_image":[{"width":500,"height":500,"url":"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1.jpg","type":"image\/jpeg"}],"author":"Comunicaci\u00f3n Leitat","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Comunicaci\u00f3n Leitat","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#article","isPartOf":{"@id":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/"},"author":{"name":"Comunicaci\u00f3n Leitat","@id":"https:\/\/leitat.org\/en\/#\/schema\/person\/ca8dc97489cd821df9e0c42930e89131"},"headline":"BATCure Kick off meeting &#8211; New therapeutic options for a group of rare lysosomal diseases","datePublished":"2016-03-04T15:39:58+00:00","dateModified":"2025-02-24T21:55:57+00:00","mainEntityOfPage":{"@id":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/"},"wordCount":124,"publisher":{"@id":"https:\/\/leitat.org\/en\/#organization"},"image":{"@id":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1.jpg","keywords":["Blog News"],"articleSection":["Health technologies"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/","url":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/","name":"New therapeutic options for a group of rare lysosomal diseases","isPartOf":{"@id":"https:\/\/leitat.org\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#primaryimage"},"image":{"@id":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1.jpg","datePublished":"2016-03-04T15:39:58+00:00","dateModified":"2025-02-24T21:55:57+00:00","description":"BATCure Kick off meeting - New therapeutic options for a group of rare lysosomal diseases. A European project funded under H2020 programme.","breadcrumb":{"@id":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#primaryimage","url":"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1.jpg","contentUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2016\/03\/batcure2-500x500-1.jpg","width":500,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/leitat.org\/en\/blog\/batcure-kick-off-meeting-new-therapeutic-options-group-rare-lysosomal-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"HOME","item":"https:\/\/leitat.org\/en\/home\/"},{"@type":"ListItem","position":2,"name":"BATCure Kick off meeting &#8211; New therapeutic options for a group of rare lysosomal diseases"}]},{"@type":"WebSite","@id":"https:\/\/leitat.org\/en\/#website","url":"https:\/\/leitat.org\/en\/","name":"Leitat Technological Center","description":"Managing Technologies","publisher":{"@id":"https:\/\/leitat.org\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/leitat.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/leitat.org\/en\/#organization","name":"Leitat Technological Center","url":"https:\/\/leitat.org\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/","url":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg","contentUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg","width":226,"height":78,"caption":"Leitat Technological Center"},"image":{"@id":"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/leitat.org\/en\/#\/schema\/person\/ca8dc97489cd821df9e0c42930e89131","name":"Comunicaci\u00f3n Leitat","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g","caption":"Comunicaci\u00f3n Leitat"},"sameAs":["https:\/\/leitat.org"],"url":"https:\/\/leitat.org\/en\/blog\/author\/comunica-wp\/"}]}},"_links":{"self":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts\/63488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/comments?post=63488"}],"version-history":[{"count":1,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts\/63488\/revisions"}],"predecessor-version":[{"id":63542,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts\/63488\/revisions\/63542"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/media\/46069"}],"wp:attachment":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/media?parent=63488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/categories?post=63488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/tags?post=63488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}